Literature DB >> 28449304

A case of familial transmission of the newly described DNMT3A-Overgrowth Syndrome.

Gabrielle Lemire1, Julie Gauthier1, Jean-François Soucy1, Marie-Ange Delrue1.   

Abstract

DNMT3A-Overgrowth Syndrome (also known as Tatton-Brown-Rahman Syndrome) (MIM 615879) has recently been described in 13 individuals with de novo heterozygous mutations in DNMT3A gene. This autosomal dominant condition is characterized by overgrowth, dysmorphic facial features and moderate intellectual disability. Missense and truncating point mutations, a small in-frame deletion, as well as microdeletion 2p23 have been reported. Moreover, DNMT3A is commonly somatically mutated in acute myeloid leukemia. We herein report a family with two siblings and their father affected by the syndrome. The proband is a 12 year-old boy with tall stature, macrocephaly, facial dysmorphism, and intellectual disability. His 10-year-old sister also has learning difficulties, overgrowth and mild facial dysmorphism. Their father is a 49 year-old man with tall stature, macrocephaly, learning difficulties, and minor facial dysmorphism. He had a right occipital osteoma removed at 20 years of age. A heterozygous splice site mutation NM_022552.4 (DNMT3A): c.2323-2A > T was found in the proband by whole exome sequencing analysis and by targeted Sanger Sequencing for the proband's sister and father. This mutation has not been previously reported and is believed to be pathogenic. Indeed, this substitution involves a highly conserved canonical splice site and is predicted to cause exon skipping. This is the first report of a familial transmission of DNMT3A-Overgrowth Syndrome, supporting the autosomal dominant inheritance. The proband's phenotype is more severe than that of his two other affected family members, which illustrates variable expressivity in the syndrome.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990DNMT3Azzm321990; zzm321990DNMT3A-Overgrowth Syndrome; Tatton-Brown-Rahman Syndrome

Year:  2017        PMID: 28449304     DOI: 10.1002/ajmg.a.38119

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  Acromegaly in the setting of Tatton-Brown-Rahman Syndrome.

Authors:  C Hage; E Sabini; H Alsharhan; J A Fahrner; A Beckers; A Daly; R Salvatori
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

2.  Aortic root dilatation and dilated cardiomyopathy in an adult with Tatton-Brown-Rahman syndrome.

Authors:  Alana C Cecchi; Amier Haidar; Isabella Marin; Callie S Kwartler; Siddharth K Prakash; Dianna M Milewicz
Journal:  Am J Med Genet A       Date:  2021-10-13       Impact factor: 2.578

Review 3.  [Tatton-Brown-Rahman syndrome associated with the DNMT3A gene: a case report and literature review].

Authors:  Min Chen; Si-Tao Li; Yao Cai; Xin Xiao; Cong-Cong Shi; Hu Hao
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-10

4.  Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients.

Authors:  Jair Tenorio; Pablo Alarcón; Pedro Arias; Irene Dapía; Sixto García-Miñaur; María Palomares Bralo; Jaume Campistol; Salvador Climent; Irene Valenzuela; Sergio Ramos; Antonio Martínez Monseny; Fermina López Grondona; Javier Botet; Mercedes Serrano; Mario Solís; Fernando Santos-Simarro; Sara Álvarez; Gisela Teixidó-Tura; Alberto Fernández Jaén; Gema Gordo; María Belén Bardón Rivera; Julián Nevado; Alicia Hernández; Juan C Cigudosa; Víctor L Ruiz-Pérez; Eduardo F Tizzano; Pablo Lapunzina
Journal:  Eur J Hum Genet       Date:  2019-11-04       Impact factor: 4.246

5.  Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging.

Authors:  Aaron R Jeffries; Reza Maroofian; Claire G Salter; Barry A Chioza; Harold E Cross; Michael A Patton; Emma Dempster; I Karen Temple; Deborah J G Mackay; Faisal I Rezwan; Lise Aksglaede; Diana Baralle; Tabib Dabir; Matthew F Hunter; Arveen Kamath; Ajith Kumar; Ruth Newbury-Ecob; Angelo Selicorni; Amanda Springer; Lionel Van Maldergem; Vinod Varghese; Naomi Yachelevich; Katrina Tatton-Brown; Jonathan Mill; Andrew H Crosby; Emma L Baple
Journal:  Genome Res       Date:  2019-06-03       Impact factor: 9.043

6.  Tatton-Brown-Rahman syndrome with a novel DNMT3A mutation presented severe intellectual disability and autism spectrum disorder.

Authors:  Takayuki Yokoi; Yumi Enomoto; Takuya Naruto; Kenji Kurosawa; Norimichi Higurashi
Journal:  Hum Genome Var       Date:  2020-05-18

Review 7.  Alterations to DNMT3A in Hematologic Malignancies.

Authors:  Kartika Venugopal; Yang Feng; Daniil Shabashvili; Olga A Guryanova
Journal:  Cancer Res       Date:  2020-10-21       Impact factor: 13.312

8.  The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants.

Authors:  Katrina Tatton-Brown; Anna Zachariou; Chey Loveday; Anthony Renwick; Shazia Mahamdallie; Lise Aksglaede; Diana Baralle; Daniela Barge-Schaapveld; Moira Blyth; Mieke Bouma; Jeroen Breckpot; Beau Crabb; Tabib Dabir; Valerie Cormier-Daire; Christine Fauth; Richard Fisher; Blanca Gener; David Goudie; Tessa Homfray; Matthew Hunter; Agnete Jorgensen; Sarina G Kant; Cathy Kirally-Borri; David Koolen; Ajith Kumar; Anatalia Labilloy; Melissa Lees; Carlo Marcelis; Catherine Mercer; Cyril Mignot; Kathryn Miller; Katherine Neas; Ruth Newbury-Ecob; Daniela T Pilz; Renata Posmyk; Carlos Prada; Keri Ramsey; Linda M Randolph; Angelo Selicorni; Deborah Shears; Mohnish Suri; I Karen Temple; Peter Turnpenny; Lionel Val Maldergem; Vinod Varghese; Hermine E Veenstra-Knol; Naomi Yachelevich; Laura Yates; Nazneen Rahman
Journal:  Wellcome Open Res       Date:  2018-04-23

9.  First identified Korean family with Tatton-Brown-Rahman Syndrome caused by the novel DNMT3A variant c.118G>C p.(Glu40Gln).

Authors:  Cha Gon Lee; Ja-Hyun Jang; Ji-Young Seo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2019-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.